Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition - Kassab - 2021 - ChemMedChem - Wiley Online Library
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1 | Oncotarget
Biomedicines | Free Full-Text | Cancer Vaccines in Ovarian Cancer: How Can We Improve? | HTML
Proposed mechanism for formation of ¹O2 by IDO1 plus H2O2 and chemical... | Download Scientific Diagram
The therapeutic potential of targeting tryptophan catabolism in cancer | British Journal of Cancer
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) | Business Wire
INCB24360 (epacadostat) – All About Drugs
Incyte climbs on combo data for IDO inhibitor epacadostat | Fierce Biotech
Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase** - Ortiz‐Meoz - 2021 - ChemBioChem - Wiley Online Library
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry - MedChemComm (RSC Publishing) DOI:10.1039/C7MD00109F
IDO Is Still A Valid Pathway For NewLink Genetics (NASDAQ:LUMO) | Seeking Alpha
Volker Schulz on Twitter: "So, will $NLNK's #indoximod, the #IDO inhibitor (that isn't really an IDO inhibitor) succeed, where #epacadostat failed? $INCY $MRK https://t.co/soLajZYdiR" / Twitter
Indoximod - an overview | ScienceDirect Topics
INCB24360 (epacadostat) – All About Drugs
IDO Is Still A Valid Pathway For NewLink Genetics (NASDAQ:LUMO) | Seeking Alpha
Frontiers | Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers | Oncology
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy - ScienceDirect
The State of IDO Inhibitor Combinations in the Treatment of Melanoma
Beyond PD-1 Immunotherapy in Malignant Melanoma | SpringerLink
aacrindoximod
IDO to I DON'T – IDO1 Inhibitor Development News
IDO Inhibitor Development Shows Fresh Signs of Life Across Tumor Types
Frontiers | Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations | Molecular Biosciences
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update | HTML
AACR-NCI-EORTC B060 IDO1 Inhibitors - Oncolines B.V.
Epacadostat - Wikipedia
